JosephLeeRoswarskiMDFACP
Hematology • Washington, DCHematologic Oncology
Lymphoma, Hematologic Malignancies Division; Lombardi Comprehensive Cancer Center; Medstar Georgetown University Hospital; Regional Cancer Care Associates
Dr. Roswarski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Lombardi Comprehensive Cancer Center
3800 Reservoir Rd NW
Washington, DC 20007Phone+1 202-444-2223Fax+1 866-871-7321- Is this information wrong?
Summary
- Dr. Joseph Roswarski is a hematologist oncologist in Washington, DC and is affiliated with MedStar Georgetown University Hospital and the Lombardi Comprehensive Cancer Center. He received his medical degree from Indiana University School of Medicine and has been in practice 11 years. He specializes in malignant hematology with focus on aggressive/indolent lymphomas, CLL, and multiple myeloma.
Education & Training
National Capital ConsortiumFellowship, Hematology and Medical Oncology, 2014 - 2017- National Capital ConsortiumResidency, Internal Medicine, 2012 - 2014
- National Capital ConsortiumInternship, Internal Medicine, 2011 - 2012
Indiana University School of MedicineClass of 2011
Certifications & Licensure
MD State Medical License 2022 - 2025
VA State Medical License 2013 - 2024
DC State Medical License 2022 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Hodgkin lymphoma: Focus on evolving treatment paradigms.Longo, D., Roswarski, J.> ;Best Practice & Research. Clinical Haematology. 2023 Dec 1
- 1 citationsSevere Lenalidomide-Associated Hyperbilirubinemia.Daniel T Gildea, Joseph L Roswarski> ;Cureus. 2023 Jan 1
- 9 citationsCarfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering ...Dickran Kazandjian, Elizabeth M. Hill, Alexander Dew, Candis Morrison, Joseph Roswarski, Neha Korde, Michael Emanuel, Ani Petrosyan, Manisha Bhutani, Katherine R. Calv...> ;JAMA Oncology. 2021 Nov 1
- Join now to see all
Journal Articles
- Hodgkin lymphoma: Focus on evolving treatment paradigmsJoseph L. Roswarski, Dan L. Longo, Best Practice & Research Clinical Haematology, 10/27/2023
Professional Memberships
- Member
- Member
- Member
Hospital Affiliations
MedStar Georgetown University HospitalWashington, District of Columbia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
